ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EXEL Exelixis Inc

23.17
0.00 (0.00%)
Pre Market
Last Updated: 04:00:06
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Exelixis Inc EXEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 23.17 04:00:06
Open Price Low Price High Price Close Price Prev Close
23.17
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
2/27/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:05BWExelixis to Webcast Fireside Chats as Part of Investor..
2/23/202418:33EDGAR2Form 144 - Report of proposed sale of securities
2/22/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202419:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202409:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/06/202416:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/06/202416:28EDGAR2Form 8-K - Current report
2/06/202416:05BWExelixis Announces Fourth Quarter and Fiscal Year 2023..
2/01/202416:05BWExelixis to Webcast Fireside Chats as Part of Investor..
1/25/202408:00BWExelixis Announces Detailed Results of Phase 3 CONTACT-02..
1/23/202416:05BWExelixis to Release Fourth Quarter and Fiscal Year 2023..
1/22/202417:00BWOpdivo® (nivolumab) in Combination with CABOMETYX®..
1/18/202416:05BWEuropean Patent Office Rules in Favor of Exelixis on..
1/16/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202421:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/09/202421:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/08/202409:06EDGAR2Form 8-K - Current report
1/07/202416:00BWExelixis Announces Preliminary Fiscal Year 2023 Financial..
1/02/202416:05BWExelixis to Present at the 42nd Annual J.P. Morgan..
12/20/202316:20EDGAR2Form 8-K - Current report
12/14/202319:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202319:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202316:56EDGAR2Form 144 - Report of proposed sale of securities
12/13/202316:27EDGAR2Form 144 - Report of proposed sale of securities
12/12/202316:26EDGAR2Form 144 - Report of proposed sale of securities
12/07/202316:05BWExelixis 2023 R&D Day: Science & Strategy to be Webcast on..
12/04/202318:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202308:02BWExelixis Announces Initiation of the STELLAR-305 Phase 2/3..
12/04/202308:00BWExelixis and Arcus Biosciences Announce Clinical Trial..
11/30/202316:10EDGAR2Form 144 - Report of proposed sale of securities
11/29/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/21/202316:05BWExelixis to Present at the Piper Sandler 35th Annual..
11/20/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202309:00BWExelixis Announces Encouraging Results from Expansion Cohort..
11/09/202316:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202316:08EDGAR2Form 8-K - Current report
11/01/202316:05BWExelixis Announces Third Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock